Clinical trial Recruiting at 1 site Interventional Ages 29 Weeks to 30 Weeks

Improving oral feeding in premature infants using a specific intervention

Official title: Effects of the Application of PIOMI (Premature Oral Motor Intervention) in the Oral Feeding of the Premature: Randomized Clinical Trial

Run by Fundació Sant Joan de Déu · NCT06395298 · Data updated 2026-11-12

This study is testing if a new feeding approach can help premature babies learn to eat on their own and breastfeed better before they leave the hospital.

Quick facts

Study typeInterventional
Ages29 Weeks to 30 Weeks
SexAll
Enrollment35 (estimated)
SponsorFundació Sant Joan de Déu
Academic / other
Locations1 site (Barcelona, Catalonia)
StatusRecruiting
StartedFebruary 13, 2023
Main results expectedJune 3, 2026
Study endsDecember 30, 2026
Registry record updatedMay 2, 2024
Trial IDNCT06395298 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are neonates born at the Sant Joan de Déu Hospital with a gestational age of 29-30 weeks who are clinically stable and require external feeding support.

Probably not a fit

Patients who are intubated, receiving exclusive parenteral nutrition, or have significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of the Premature Oral Motor Intervention (PIOMI) combined with the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) in facilitating oral feeding in premature infants. The study will assess whether this combined approach allows for the safe withdrawal of external feeding devices while maintaining adequate nutritional status and improving breastfeeding rates at hospital discharge. The trial will take place in a neonatal intensive care unit at a tertiary hospital, focusing on infants born between 29-30 weeks gestational age who are currently reliant on external feeding devices due to feeding difficulties.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance the ability of premature infants to feed orally, potentially reducing hospital stays and improving breastfeeding outcomes.

How similar studies have gone: Previous studies have shown promising results with the PIOMI approach, indicating a high success rate in initiating oral feeding in preterm infants.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Neonates born at the Sant Joan de Déu Hospital with a gestational age between 29-30 weeks carrying an external feeding device due to the difficulty of oral feeding and that the medical team in charge considers clinically stable.

Exclusion Criteria:

* Endotracheal intubation or high-flow ventilatory support.
* Exclusive parenteral nutrition.
* Hyporeactive due to the use of sedative drugs.
* Condition of prematurity associated with other pathologies (syndromes, acquired brain damage, gastrointestinal malformations, airway and craniofacial malformations).

Where it's running

  • Raquel García Ezquerra
    Barcelona, Catalonia, Spain
    Recruiting

Study contacts

  • Principal investigator: Raquel García Ezquerra — Sant Joan de Déu Hospital
  • Study coordinator: Raquel García Equerra
  • Email: raquel.garciae@sjd.es
  • Phone: 639423251

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.